The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.

During clinical trials, it became apparent that patients were experiencing significant weight loss. This discovery has led to Semaglutide being prescribed off-label for weight management, although it is not approved by the South African Health Products Regulatory Authority (SAHPRA) for this purpose.

A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.

While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects. Commonly reported issues include: nausea, constipation and “Ozempic face,” a condition where rapid weight loss leads to a gaunt appearance.

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and those who can afford to buy them. Drugs like Ozempic, which isn’t available in New Zealand,